187 related articles for article (PubMed ID: 16879247)
1. Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.
Baril L; Dietemann J; Essevaz-Roulet M; Béniguel L; Coan P; Briles DE; Guy B; Cozon G
Clin Exp Immunol; 2006 Aug; 145(2):277-86. PubMed ID: 16879247
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
3. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
Moore QC; Bosarge JR; Quin LR; McDaniel LS
Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
Coats MT; Benjamin WH; Hollingshead SK; Briles DE
Vaccine; 2005 Jul; 23(33):4257-62. PubMed ID: 16005736
[TBL] [Abstract][Full Text] [Related]
5. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
6. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
[TBL] [Abstract][Full Text] [Related]
7. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
Schmid P; Selak S; Keller M; Luhan B; Magyarics Z; Seidel S; Schlick P; Reinisch C; Lingnau K; Nagy E; Grubeck-Loebenstein B
Vaccine; 2011 May; 29(23):3982-9. PubMed ID: 21481328
[TBL] [Abstract][Full Text] [Related]
8. Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy.
Goulart C; Rodriguez D; Kanno AI; Lu YJ; Malley R; Leite LC
Vaccine; 2017 Mar; 35(13):1683-1691. PubMed ID: 28242071
[TBL] [Abstract][Full Text] [Related]
9. Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea.
Francis JP; Richmond PC; Strickland D; Prescott SL; Pomat WS; Michael A; Nadal-Sims MA; Edwards-Devitt CJ; Holt PG; Lehmann D; van den Biggelaar AH
Clin Exp Immunol; 2017 Mar; 187(3):408-417. PubMed ID: 27859014
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
Miyaji EN; Dias WO; Tanizaki MM; Leite LC
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):53-7. PubMed ID: 12770760
[TBL] [Abstract][Full Text] [Related]
11. T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease.
Mureithi MW; Finn A; Ota MO; Zhang Q; Davenport V; Mitchell TJ; Williams NA; Adegbola RA; Heyderman RS
J Infect Dis; 2009 Sep; 200(5):783-93. PubMed ID: 19642930
[TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
Arulanandam BP; Lynch JM; Briles DE; Hollingshead S; Metzger DW
Infect Immun; 2001 Nov; 69(11):6718-24. PubMed ID: 11598043
[TBL] [Abstract][Full Text] [Related]
13. Basophil expansion protects against invasive pneumococcal disease in mice.
Bischof A; Brumshagen C; Ding N; Kirchhof G; Briles DE; Gessner JE; Welte T; Mack M; Maus UA
J Infect Dis; 2014 Jul; 210(1):14-24. PubMed ID: 24470504
[TBL] [Abstract][Full Text] [Related]
14. Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients.
Kolberg J; Aase A; Naess LM; Aaberge IS; Caugant DA
Pathog Dis; 2014 Feb; 70(1):40-50. PubMed ID: 24151210
[TBL] [Abstract][Full Text] [Related]
15. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
Ferreira DM; Oliveira ML; Moreno AT; Ho PL; Briles DE; Miyaji EN
Microb Pathog; 2010 Jun; 48(6):205-13. PubMed ID: 20206678
[TBL] [Abstract][Full Text] [Related]
16. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
Hanniffy SB; Carter AT; Hitchin E; Wells JM
J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
[TBL] [Abstract][Full Text] [Related]
17. Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.
Habets MN; van Selm S; van Opzeeland FJ; Simonetti E; Hermans PWM; de Jonge MI; Diavatopoulos DA
Vaccine; 2016 Nov; 34(48):5968-5974. PubMed ID: 27771185
[TBL] [Abstract][Full Text] [Related]
18. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
19. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic protein contaminants in pneumococcal vaccines.
Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
